Clinical Experience with New Antiepileptic Drugs: Antiepileptic Drugs in Europe

@article{Loiseau1999ClinicalEW,
  title={Clinical Experience with New Antiepileptic Drugs: Antiepileptic Drugs in Europe},
  author={Pierre Loiseau},
  journal={Epilepsia},
  year={1999},
  volume={40}
}
The use of antiepileptic drugs (AEDs), singly and in combination, has been marked by variation among European countries and by a slow progress toward a standard of care that is still far from uniform. Phenobarbital, phenytoin, trimethadione, and primidone, given in various combinations, were the predominant agents used in the first half of this century. Prescribing habits differed among the Latin countries, the United Kingdom, and Scandinavia, based on local trends, divergent teaching… 
The evolution of antiepileptic drug development and regulation
TLDR
Changes in approach to antiepileptic drug development reflect a more patient-centric approach to treatment, since it is now recognised that epilepsy can only be effectively managed if patients’ individual real-life needs are addressed, since a key to successful treatment is long-term compliance.
Pharmacokinetics of Phenobarbital During Certain Enhanced Elimination Modalities to Evaluate Their Clinical Efficacy in Management of Drug Overdose
TLDR
The authors conclude that the management of drug overdose in the case of weak acidic drugs that have small volumes of distribution should include the sole use of MDAC and supportive care, without urinary alkalinization.
Lamotrigine Treatment During Amygdala‐Kindled Seizure Development Fails to Inhibit Seizures and Diminishes Subsequent Anticonvulsant Efficacy
Purpose: Lamotrigine (LTG) is an anticonvulsant that is currently in use for the treatment of various seizure disorders and that shows promise in the treatment of affective illness. LTG is also
Lamotrigine Treatment During Amygdala‐Kindled Seizure Development Fails to Inhibit Seizures and Diminishes Subsequent Anticonvulsant Efficacy
TLDR
LTG possesses potent anticonvulsant effects on completed amygdala-kindled seizures, and exposure to LTG during kindled seizure development leads to a reduced subsequent response to the drug in fully kindled animals, suggesting that different stages of kindling (epileptogenesis versus fully manifest seizures) may have different underlying neural mechanisms that require distinct pharmacotherapies.
Why we urgently need improved epilepsy therapies for adult patients
TLDR
Improved understanding of epilepsy mechanisms, identification of potential new therapeutic targets, and their assessment in randomized controlled trials are needed to reduce the burden of refractory epilepsy.
Highights in the History of Epilepsy: The Last 200 Years
The purpose of this study was to present the evolution of views on epilepsy as a disease and symptom during the 19th and the 20th century. A thorough study of texts, medical books, and reports along
Treatment of pediatric epilepsy: European expert opinion, 2007.
TLDR
Within the limits of expert opinion and with the understanding that new research data may take precedence, the experts' recommendations provide helpful guidance in situations where the medical literature is scant or lacking.
Quality of life and treatment satisfaction in Spanish epilepsy patients on monotherapy with lamotrigine or valproic acid
TLDR
Chronic patients with epilepsy already treated with lamotrigine slightly improved HRQoL at 6 month follow up, whereas no significant changes were observed in the valproic acid group.
Seizures in the Adult Intensive Care Unit
TLDR
Most seizures occur singly, and recurrence is usually prevented with initiation of anticonvulsant therapy, however, status epilepticus may develop, which requires emergent treatment before irreversible brain injury occurs.
Antiepileptic Drugs and Bone Health
TLDR
Epilepsy is a disorder affecting brain function that leads to the periodic and unpredictable occurrence of seizures that encompasses several forms of seizure disorders that lead to the sudden and disorderly discharge of cerebral neurons.
...
1
2
...

References

SHOWING 1-10 OF 50 REFERENCES
The new generation of antiepileptic drugs: advantages and disadvantages.
  • E. Perucca
  • Medicine
    British journal of clinical pharmacology
  • 1996
TLDR
There is evidence that lamotrigine, zonisamide, felbamate and, possibly, topiramate may also be effective in generalized epilepsies, and further studies are required to characterize their activity spectrum as well as their potential value in monotherapy.
Antiepileptic Drug Monitoring: A Reappraisal
TLDR
Blood level determinations of certain of the new, less familiar AEDs, including felbamate, lamotrigine, and oxcarbazapine, appear to be useful, however, new approaches are needed to monitor the efficacy and possible toxicity of other new A EDs for which the correlation between blood concentration of AED and clinical outcome is less clear.
Monotherapy or polytherapy for epilepsy?
  • A. Guberman
  • Medicine
    The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques
  • 1998
TLDR
The theoretical advantages of monotherapy and monotherapy with traditional and newer AEDs are reviewed, taking advantage of possible synergism, a yet unproven concept.
Phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed adult epilepsy: a randomised comparative monotherapy trial.
TLDR
In patients with newly diagnosed tonic-clonic or partial with or without secondary generalised seizures, the choice of drug will be more influenced by considerations of toxicity and costs.
Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures.
TLDR
Overall, carbamazepine and phenytoin are recommended drugs of first choice for single-drug therapy of adults with partial or generalized tonic-clonic seizures or with both.
Antiepileptic Drug Monitoring at the Epilepsy Clinic: A Prospective Evaluation
TLDR
On‐site AED monitoring had an immediate impact on clinical decision‐making in > 23% of consultations but in a form more subtle than the simple quest for a therapeutic result.
A new drug for petit mal epilepsy
TLDR
A-ethyl-a-methylsuccinimide, hereafter designated by its laboratory number of PM 871, is the third compound and the subject of this research, and will become an invaluable addition to the therapeutic armamentarium in the treatment of epilepsy when its effectiveness is more generally known.
Monotherapy or Poly therapy for Epilepsy?
Summary: Although anticonvulsant polytherapy has been widely and traditionally used in the treatment of epilepsy, there is little evidence of its advantages over monotherapy. It does, however, lead
Antiepileptic Properties of Clobazam, a 1–5 Benzodiazepine, in Man
TLDR
There is an urgent need for intensive study of the basic mechanism governing exhaustion of the antiepileptic properties of the benzodiazepines in general and of clobazam in particular.
SODIUM DIPHENYL HYDANTOINATE IN THE TREATMENT OF CONVULSIVE DISORDERS
TLDR
An experimental procedure is devised which would produce convulsive seizures in animals at a constant threshold and which would allow for a qualitative and roughly quantitative determination of anticonvulsant compounds.
...
1
2
3
4
5
...